Total Funding
52
23
Total FundingVenture - Series Unknown raised
Growth Score
-14 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
500585
Synarc Inc., a Maynard, Mass.-based provider of medical imaging and molecular marker services for clinical trials.
Acquired by 
BioClinica
Harry K. Genant: Co-Founder, Emeritus Chairman of the Board of Directors, and Senior Consultant
About the Company
Synarc is the world's largest Central Radiology service dedicated exclusively to clinical trials. Synarc's in-house radiologists and scientists are leading authorities in the use of medical imaging and molecular markers in drug development, and have pioneered many methods currently used in clinical trials. With six offices around the
world, Synarc currently manages over 150 clinical trials, involving more than 50,000 patients at 1,500 sites worldwide. Our services integrate all aspects of the design and execution of imaging and molecular markers in clinical trials across a spectrum of diseases in Oncology, Arthritis, Osteoporosis, Neurology, and Orthopaedics.
